Evidence map›Paper›PMID 23071107›Full record

ArticleThe Journal of biological chemistry2012

Characterization of the molecular architecture of human caveolin-3 and interaction with the skeletal muscle ryanodine receptor.

Gareth Whiteley, Richard F Collins, Ashraf Kitmitto

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Caveolae: Metabolic Platforms at the Crossroads of Health and Disease.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. A Role for Caveolin-3 in the Pathogenesis of Muscular Dystrophies.International journal of molecular sciences · 2020
    Review
  11. Review
  12. Model for the architecture of caveolae based on a flexible, net-like assembly of Cavin1 and Caveolin discs.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  13. Unraveling the architecture of caveolae.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gareth WhiteleySchool of Biomedicine, Cardiovascular Group, Faculty of Medical and Human Sciences, University of Manchester, Manchester M13 9NT, UK.
Richard F Collins
Ashraf Kitmitto
University of Manchester · GB

Funding

British Heart Foundation FS/08/038/25262British Heart Foundation RG/11/2/28701
6 · The paper itself

Abstract

backgroundCaveolin-3 facilitates both caveolae formation and a range of cell signaling pathways, including Ca(2+) homeostasis.

resultsCaveolin-3 forms a disc-shaped nonamer that binds the Ca(2+)-release channel, RyR1.

conclusionMultiple caveolin-3 nonamers bind to a single RyR1 homotetramer. SIGNIFICANCE: First three-dimensional structural insights into caveolin-3 assembly, interactions with RyR1 suggest a novel role in muscle contraction and/or for channel localization within the membrane. Caveolin-3 (cav-3), an integral membrane protein, is a building block of caveolae as well as a regulator of a number of physiological processes by facilitating the formation of multiprotein signaling complexes. We report that the expression of cav-3 in insect (Sf9) cells induces caveola formation, comparable in size with those observed in native tissue. We have also purified the recombinant cav-3 determining that it forms an oligomer of ∼220 kDa. We present the first three-dimensional structure for cav-3 (using transmission electron microscopy and single particle analysis methods) and show that nine cav-3 monomers assemble to form a complex that is toroidal in shape, ~16.5 nm in diameter and ~ 5.5 nm in height. Labeling experiments and reconstitution of the purified cav-3 into liposomes have allowed a proposal for the orientation of the protein with respect to the membrane. We have identified multiple caveolin-binding motifs within the ryanodine receptor (RyR1) sequence employing a bioinformatic analysis. We have then shown experimentally that there is a direct interaction between recombinant cav-3 nonamers and purified RyR1 homotetramers that would imply that at least one of the predicted cav-3-binding sites is exposed within the fully assembled RyR1 structure. The cav-3 three-dimensional model provides new insights as to how a cav-3 oligomer can bind multiple partners in close proximity to form signaling complexes. Furthermore, a direct interaction with RyR1 suggests a possible role for cav-3 as a modifier of muscle excitation-contraction coupling and/or for localization of the receptor to regions of the sarcoplasmic reticulum.

Indexed as

CalciumCaveolaeCaveolin 3DimerizationHumansModels, MolecularMuscle, SkeletalProtein BindingRyanodine Receptor Calcium Release ChannelCalciumCaveolin 3Ryanodine Receptor Calcium Release Channel

Identifiers

PMID23071107
PMCPMC3504746
OpenAlexW2087657091

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.